Skip to main content
. 2017 Feb 6;8(10):16642–16649. doi: 10.18632/oncotarget.15120

Table 2. CF-DNA quantity (ng) in relation to the status (cancer/control).

Gene Overall(n = 89) Cancer(n = 79) Control(n = 10) p-value#
Median (iqr range) Median (iqr range) Median (iqr range)
HER2 LONG 0.031 (0.012–0.121) 0.034 (0.011–0.137) 0.023 (0.015–0.033) 0.439
HER2 SHORT 0.202 (0.077–0.496) 0.238 (0.093–0.509) 0.067 (0.049–0.111) 0.016
BCAS1 LONG 0.241 (0.093–0.820) 0.266 (0.131–0.941) 0.039 (0.031–0.460) 0.021
BCAS1 SHORT 1.195 (0.476–2.069) 1.259 (0.536–2.133) 0.085 (0.050–0.916) 0.001
MYC LONG 0.421 (0.190–1.192) 0.421 (0.146–1.205) 0.426 (0.299–0.533) 0.658
MYC SHORT 1.124 (0.557–2.001) 1.145 (0.557–2.255) 0.771 (0.457–1.335) 0.193
PI3KCA LONG 0.089 (0.036–0.347) 0.108 (0.036–0.373) 0.056 (0.044–0.092) 0.398
PI3KCA SHORT 1.165 (0.231–3.434) 1.619 (0.296–4.332) 0.174 (0.140–0.390) 0.001

#Two-sample Wilcoxon rank-sum (Mann-Whitney) test.